Parallel Advisors’s BioNTech BNTX Stock Holding History
Bought
Maintained
Sold
Other funds holding BNTX
LA
Parallel Advisors's BNTX Position: Q2 2026 in Review
Parallel Advisors increased its BioNTech (BNTX) stake by 115% in Q2 2026, buying an estimated $28.2K and bringing the position to 561 shares worth $52.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2111.
Parallel Advisors first reported a position in BNTX in Q2 2020 and has held it in 25 quarters since. The position peaked at $91K in Q4 2021. 112 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.
- Parallel Advisors held 561 shares of BioNTech worth $52.2K as of Q2 2026.
- Parallel Advisors bought 300 BioNTech shares in Q2 2026, an estimated $28.2K.
- BioNTech made up ﹤0.01% of Parallel Advisors's portfolio in Q2 2026, its #2111 holding.
- Parallel Advisors first reported a position in BioNTech in Q2 2020 and has held it in 25 quarters since.
- Parallel Advisors's BioNTech position peaked at $91K in Q4 2021.
- 112 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.
Based on Parallel Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.